EPM, EMND, and EDM: The Role Vitamin E Plays in Every One

Vitamin E is one of the more thoroughly researched nutrients in equine nutrition, with a well-established role in muscle function, nervous system health, immune modulation, and antioxidant protection. It is also one of the most commonly deficient nutrients in horses that spend significant time off pasture.

Unlike some nutrients the horse can synthesize internally, vitamin E is entirely diet-dependent. Horses evolved to obtain it primarily through fresh, green grass. When that access is reduced — through stalling, dry lots, hay-based diets, drought, or heavy training schedules — vitamin E levels can decline over time.

For most horses, suboptimal vitamin E status is a nutritional gap worth addressing. For horses managing neurological conditions such as EPM, equine motor neuron disease (EMND), or equine degenerative myeloencephalopathy (EDM), adequate vitamin E status may be an important part of the overall management picture — though the role it plays varies by condition.

Vitamin E functions primarily as a fat-soluble antioxidant. Its core role is protecting cell membranes from oxidative damage — the process that occurs when free radicals accumulate faster than the body's natural defense systems can neutralize them.

Veterinary consensus, including guidance from the UC Davis School of Veterinary Medicine, supports its role in two areas in particular:

• Muscle tissue — exercise increases oxidative stress. Adequate vitamin E is associated with reduced oxidative damage to muscle cells and may support recovery following intense work.
• Nervous system tissue — nerve cells are particularly sensitive to oxidative damage. Vitamin E is considered important for maintaining normal neuromuscular function, and deficiency has been associated with several neurological conditions in horses.

According to the UC Davis School of Veterinary Medicine, vitamin E functions as a biological antioxidant that serves to maintain normal neuromuscular function in horses. Long-term deficiency has been associated with serious and, in some cases, irreversible neurological changes.

Fresh pasture is a horse's primary natural source of vitamin E. When access is limited or eliminated, deficiency risk increases. Horses most commonly identified as candidates for supplementation include:

• Stall-kept and performance horses — horses with limited turnout or restricted pasture access may not consume enough fresh forage to maintain adequate alpha-tocopherol levels
• Horses on hay-based diets — vitamin E degrades rapidly once grass is cut and dried; hay provides substantially less vitamin E than live pasture
• Horses in hot or dry climates — limited growing seasons and drought conditions reduce both pasture availability and quality
• Young foals and senior horses — both age groups have elevated needs and may be more vulnerable to deficiency-related complications
• Broodmares in late pregnancy and lactation — vitamin E is transferred through milk and supports foal immune and neuromuscular development
• Horses with neurological conditions — horses being managed for EPM, EMND, or EDM are often placed on higher vitamin E protocols as part of their overall care plan, in consultation with a veterinarian
• Horses under physical or environmental stress — illness, injury, transport, and competition can increase oxidative load, which may elevate vitamin E requirements

Vitamin E appears across the veterinary literature on equine neurological disease — but its role varies meaningfully between conditions. Understanding those distinctions is important for setting accurate expectations.

EPM (Equine Protozoal Myeloencephalitis)

EPM is a parasitic disease caused primarily by Sarcocystis neurona that affects the brain, spinal cord, and nervous system. Signs range from mild incoordination to severe neurological instability, and its variable presentation makes early identification challenging.

Vitamin E does not treat or prevent EPM — antiprotozoal medication is required for that. However, the AAEP recommends 10,000 IU of vitamin E per day as part of the nutritional support protocol during EPM treatment. The rationale is that nervous system tissue affected by the disease is particularly vulnerable to oxidative stress, and maintaining adequate antioxidant status may support the tissue environment during recovery. Kentucky Equine Research emphasizes that natural vitamin E should be considered as part of any nutritional support plan for horses with neurological disease.

In summary: vitamin E is supportive, not curative, in the context of EPM.

EMND (Equine Motor Neuron Disease)

EMND is a neurodegenerative condition affecting the motor neurons that control skeletal muscle. First described in 1990, it shares some features with human motor neuron disease. Affected horses typically show progressive weakness, muscle wasting, weight loss, and a characteristic low-head stance.

The association between chronic vitamin E deficiency and EMND is among the strongest in equine neurology. A field study published in BMC Veterinary Research found that plasma vitamin E levels declined significantly in horses maintained on vitamin E-deficient diets and that this deficiency was strongly associated with EMND development over time. That said, not all vitamin E-deficient horses develop EMND — individual susceptibility, oxidative load, and other factors appear to play a role. Horses diagnosed with EMND are typically managed with 6,000–10,000 IU of vitamin E daily.

EDM (Equine Degenerative Myeloencephalopathy) and eNAD

EDM and the related condition equine neuroaxonal dystrophy (eNAD) are developmental neurological diseases typically presenting in young horses as progressive ataxia. Research from the UC Davis Finno Laboratory has highlighted the relationship between vitamin E deficiency and these conditions.

Importantly, EDM is not caused solely by vitamin E deficiency — genetic predisposition and environmental factors are also implicated. Vitamin E deficiency is considered a significant risk factor, particularly during development, but the relationship is multifactorial. Horses with EDM do not consistently respond to vitamin E supplementation once neurological damage has occurred, which underscores the value of maintaining adequate levels before deficiency becomes a problem. A subset of horses with vitamin E-responsive myopathy (VEM) do show improvement with high-dose supplementation, but this does not apply universally to EDM cases.

Not all vitamin E supplements deliver equivalent results, and the research on bioavailability between natural and synthetic forms is fairly clear.

Natural vitamin E (d-alpha-tocopherol) contains a single molecular isomer that the body preferentially absorbs and retains. Synthetic vitamin E (dl-alpha-tocopherol) is a mixture of eight isomers, only one of which is structurally equivalent to the natural form. The remaining isomers are absorbed and retained less efficiently.

Research from Kentucky Equine Research using Thoroughbreds found that natural-source water-dispersible vitamin E was approximately 5–6 times more bioavailable than synthetic vitamin E acetate at equivalent IU doses, with a 5,000 IU dose more than doubling serum vitamin E levels within 12 hours.

For neurological cases specifically, research cited by KER found that natural alpha-tocopherol supplementation elevated cerebrospinal fluid (CSF) concentrations of vitamin E, while synthetic vitamin E at equivalent high doses did not produce the same effect. Given that the nervous system is the primary tissue of concern in conditions like EPM and EMND, this distinction is worth discussing with your veterinarian when selecting a supplement.